The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model

H Héctor Frayde-Gómez B Brenda Chimal-Vega A Angel Pulido-Capiz A Andrea Muñoz-Ayala O Octavio Galindo-Hernández J José Luis Vique-Sanchez A Ana Gabriela Leija-Montoya R Raúl Díaz-Molina P Pablo A. Madero-Ayala M Marco A. Ramos-Ibarra V Victor García-González

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 07, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (11)

H

Héctor Frayde-Gómez

B

Brenda Chimal-Vega

A

Angel Pulido-Capiz

A

Andrea Muñoz-Ayala

O

Octavio Galindo-Hernández

J

José Luis Vique-Sanchez

A

Ana Gabriela Leija-Montoya

R

Raúl Díaz-Molina

P

Pablo A. Madero-Ayala

M

Marco A. Ramos-Ibarra

V

Victor García-González